Online citations, reference lists, and bibliographies.

Experimental Metastasis: Modeling And Analysis

A. Malek
Published 2013 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Only for you today! Discover your favourite experimental metastasis modeling and analysis book right here by downloading and getting the soft file of the book. This is not your time to traditionally go to the book stores to buy a book. Here, varieties of book collections are available to download. One of them is this experimental metastasis modeling and analysis as your preferred book. Getting this book b on-line in this site can be realized now by visiting the link page to download. It will be easy. Why should be here?
This paper references
10.1152/physrev.00033.2007
LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.
A. P. Lillis (2008)
Pattern of secondary genomic changes in pancreatic tumors of Tgf alpha/Trp53+/- transgenic mice.
B. Schreiner (2003)
10.1038/nature09515
Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer
S. Yachida (2010)
10.2144/96202RR05
Method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer.
M. Vrancken Peeters (1996)
10.1196/annals.1413.020
Molecular control of lymphatic metastasis.
M. Achen (2008)
10.1158/0008-5472.CAN-06-0339
Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells.
T. Enomoto (2006)
10.1158/0008-5472.CAN-05-2383
Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.
A. I. Garbe (2006)
10.1038/nature09460
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
P. Campbell (2010)
10.3791/1977
Murine bioluminescent hepatic tumour model.
Simon Rajendran (2010)
10.1158/1078-0432.CCR-09-1039
Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
D. Palmieri (2009)
10.1097/CJI.0b013e3181eb826d
Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12
D. Zaharoff (2010)
10.1073/pnas.0810097105
Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice
N. Habbe (2008)
10.1089/104454904323145254
Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells.
A. Albig (2004)
10.1016/J.YSUR.2011.08.015
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
K. Behrns (2012)
10.1021/bc800148t
Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.
W. Pardridge (2008)
10.1021/ar200023x
Theranostic nanoshells: from probe design to imaging and treatment of cancer.
R. Bardhan (2011)
10.1016/j.bbrc.2009.02.126
Comparison of ras-responsive gene enhancers in pancreatic tumor cells that express either wild-type or mutant K-ras.
Phillip J. Wilder (2009)
10.1182/BLOOD-2006-05-021758
VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites.
S. Hirakawa (2007)
10.1158/0008-5472.CAN-05-2958
Dual-color imaging of nuclear-cytoplasmic dynamics, viability, and proliferation of cancer cells in the portal vein area.
K. Tsuji (2006)
10.1007/s00125-011-2316-0
Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
V. Grote (2011)
10.1208/s12248-008-9018-7
Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy
Marc-André Bellavance (2008)
10.1053/j.gastro.2010.03.034
Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma.
J. Morton (2010)
10.1007/s10585-012-9489-x
The connectivity of lymphogenous and hematogenous tumor cell dissemination: biological insights and clinical implications
Jonathan P. Sleeman (2012)
10.1016/j.cell.2004.11.004
Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome
K. Olive (2004)
10.1101/cshperspect.a003848
In vivo imaging in cancer.
J. Condeelis (2010)
10.1007/s11060-012-0838-z
PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas
Pramila Ramani (2012)
10.1002/ijc.25399
An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma
C. Jacobs (2011)
10.1002/ijc.2910150505
Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas
M. Lieber (1975)
10.1007/s10585-008-9221-z
Effect of anti-fibrinolytic therapy on experimental melanoma metastasis
Jennifer M. Kirstein (2008)
10.1002/jso.21794
Experimental models to study lymphatic and blood vascular metastasis
L. Chen (2011)
10.1016/j.ijrobp.2009.06.059
The PPARalpha agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation.
S. Ramanan (2009)
10.1007/s00428-006-0191-8
Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes
H. Immervoll (2006)
10.1038/nrd2614
Nanoparticle therapeutics: an emerging treatment modality for cancer
M. Davis (2008)
10.1001/ARCHSURG.133.4.383
Wound-induced tumor progression: a probable role in recurrence after tumor resection.
S. Hofer (1998)
Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.
T. Corbett (1984)
10.1002/ijc.26027
Do all roads lead to Rome? Routes to metastasis development
J. Sleeman (2011)
10.1126/science.1171362
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
K. Olive (2009)
10.1158/0008-5472.CAN-06-4167
Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
Kyoko Kojima (2007)
10.1002/MRM.10417
Imaging single mammalian cells with a 1.5 T clinical MRI scanner.
Paula Foster-Gareau (2003)
10.1093/annonc/mdn386
The effects of surgery on tumor growth: a century of investigations.
R. Demicheli (2008)
10.1002/cncr.11150
Animal models of bone metastasis
Thomas J. Rosol (2004)
Advances in Brief The Mutant Kras Oncogene Causes Pancreatic Periductal Lymphocytic Infiltration and Gastric Mucous Neck Cell Hyperplasia in Transgenic Mice 1
F. Brembeck (2003)
10.1016/j.ccr.2010.10.015
Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer.
F. Skoulidis (2010)
10.1101/GAD.1158703
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.
A. Aguirre (2003)
10.1158/0008-5472.CAN-10-4455
Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis.
J. Hood (2011)
Correlation between lymphangiogenesis and clinicopathological parameters in renal cell carcinoma.
Ilyas Ozardili (2012)
10.1242/dmm.003707
Loss of fibulin-5 binding to β1 integrins inhibits tumor growth by increasing the level of ROS
Marie K. Schluterman (2010)
10.1002/jcp.21494
Tumor lymphangiogenesis and melanoma metastasis
Matthias Rinderknecht (2008)
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
M. Tascilar (2001)
10.1158/1078-0432.CCR-09-2384
Development of an Orthotopic Model of Invasive Pancreatic Cancer in an Immunocompetent Murine Host
W. Tseng (2010)
TGF alpha transgenic mice. A model of pancreatic cancer development.
F. Greten (2001)
10.1007/s00262-010-0923-0
Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model
H. Ishizaki (2010)
10.1517/14656560903179325
Motexafin gadolinium: a novel radiosensitizer for brain tumors
Dave B Francis (2009)
10.1136/gut.2009.188961
The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer
V. Fendrich (2009)
10.1073/PNAS.0601273103
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.
N. Bardeesy (2006)
Nanocarriers as an emerging platform for cancer therapy
S. Wise (2007)
10.1158/1535-7163.MCT-07-2359
Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery
Albert Lo (2008)
10.1021/ar2000259
Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
J. Lee (2011)
10.1158/1078-0432.CCR-09-0227
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
A. Blackford (2009)
10.4049/jimmunol.0902609
Induction of Th17 Cells in the Tumor Microenvironment Improves Survival in a Murine Model of Pancreatic Cancer
Jennifer L. Gnerlich (2010)
10.1073/pnas.1002423107
Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma
P. Mazur (2010)
10.1002/cncr.22559
Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma
J. Lee (2007)
10.1371/journal.pone.0031384
Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation
S. Arnold (2012)
10.1016/J.CCR.2007.01.017
Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
Kamel Izeradjene (2007)
10.1158/1078-0432.CCR-06-0436
The Use of Targeted Mouse Models for Preclinical Testing of Novel Cancer Therapeutics
K. Olive (2006)
10.4049/jimmunol.182.3.1746
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer1
M. Tan (2009)
10.1136/gut.2007.148189
Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer
G. Feldmann (2008)
10.1038/nm1447
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
P. H. Thaker (2006)
10.1016/J.IJROBP.2005.10.013
Radiation sensitization with redox modulators: a promising approach.
A. Rosenberg (2006)
10.1124/mol.107.041236
Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors
S. Emanuel (2008)
10.1242/dmm.003228
Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma
S. Arnold (2010)
10.1002/MRM.20747
In vivo magnetic resonance imaging of single cells in mouse brain with optical validation.
C. Heyn (2006)
10.1007/s10689-010-9329-6
Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families
E. Slater (2010)
10.1126/science.1171202
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
S. Jones (2009)
10.1083/jcb.200105060
The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity
C. Pin (2001)
10.1007/978-3-642-57151-0_6
The lymph node as a bridgehead in the metastatic dissemination of tumors.
J. Sleeman (2000)
10.1073/pnas.1111840108
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
J. Gillet (2011)
10.1186/1757-2215-2-12
Ovarian cancer mouse models: a summary of current models and their limitations
M. Fong (2009)
10.1016/S0140-6736(00)49915-0
The distribution of secondary growths in cancer of the breast. 1889.
S. Paget (1989)
10.1158/1940-6207.CAPR-10-0197
Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
K. Liby (2010)
10.1200/JCO.1997.15.6.2403
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
H. Burris (1997)
10.1038/ng959
The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors
Y. Kawaguchi (2002)
10.1007/s00535-003-1119-6
Abnormalities of tumor suppressor gene p16in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters
K. Ohtsubo (2003)
10.1016/j.jamcollsurg.2008.03.003
Molecular mechanisms for individualized cancer care.
J. Mansour (2008)
10.1038/nmat2992
The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers
C. Ashley (2011)
10.1093/annonc/mdr398
Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies.
D. Aune (2012)
10.1158/0008-5472.CAN-09-0015
Genetic mutations associated with cigarette smoking in pancreatic cancer.
A. Blackford (2009)
10.1002/anie.200802469
Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery.
J. Kim (2008)
10.1093/jnci/djn216
Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain.
B. Gril (2008)
Role of p53 mutations on survival after pancreatoduodenectomy for ductal adenocarcinoma of the pancreatic head.
G. Gazzaniga (2001)
10.1002/path.2656
Bioluminescent imaging: a critical tool in pre-clinical oncology research.
K. O'Neill (2010)
10.1158/0008-5472.CAN-09-3892
Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer.
Sean P Dineen (2010)
10.1002/MRM.20718
In vivo detection of single cells by MRI.
E. Shapiro (2006)
10.1158/1940-6207.CAPR-10-0258
Deploying Mouse Models of Pancreatic Cancer for Chemoprevention Studies
P. Grippo (2010)
10.1073/pnas.0701117104
The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia
C. Carrière (2007)
10.1097/CJI.0b013e318189f13c
Tumor-derived TGF-β Mediates Conversion of CD4+Foxp3+ Regulatory T Cells in a Murine Model of Pancreas Cancer
Tricia A. Moo-Young (2009)
10.1038/415168a
Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo
H. Yanagisawa (2002)
10.1101/GAD.1478706
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
N. Bardeesy (2006)
10.1093/JNCI/95.3.214
BRCA2 Germline Mutations in Familial Pancreatic Carcinoma
S. Hahn (2003)
10.1215/15228517-2008-072
Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases.
J. Hoffmann (2009)
10.1016/S1535-6108(03)00309-X
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.
S. Hingorani (2003)
10.1007/BF00132981
Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis
Vincent L. Morris (2004)
10.1158/0008-5472.CAN-06-2662
In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases.
M. Bouvet (2006)
10.1016/S0092-8674(00)80452-3
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF
T. Kamijo (1997)
10.1158/0008-5472.CAN-05-2305
Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma.
D. Tuveson (2006)
Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.
G. Naumov (2002)
10.1007/s12032-012-0229-5
Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer
Shi-dai Jin (2012)
10.1002/BIES.10156
Cancer spread and micrometastasis development: Quantitative approaches for in vivo models
I. Macdonald (2002)
10.1101/GAD.184701
A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease.
M. Wagner (2001)
10.1055/s-0038-1647480
PAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines--evidence that the liver contributes to acute phase behaviour of PAI-1.
J. de Boer (1991)
10.1016/J.CCR.2005.04.023
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.
S. Hingorani (2005)
10.1038/35092592
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Norman E. Sharpless (2001)
10.1371/journal.pone.0010347
Isoform-Specific Upregulation of Palladin in Human and Murine Pancreas Tumors
S. Goicoechea (2010)
10.1016/j.ejca.2010.02.039
Cancer metastasis as a therapeutic target.
J. Sleeman (2010)
10.3181/0801-RM-12
Forced Expression of MMP9 Rescues the Loss of Angiogenesis and Abrogates Metastasis of Pancreatic Tumors Triggered by the Absence of Host SPARC
S. Arnold (2008)
10.1371/journal.pmed.0030516
Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer Mechanism
K. Pogue-Geile (2006)
10.1128/MCB.13.1.320
Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver.
E. Sandgren (1993)
10.1200/JCO.2006.09.9861
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
L. Muldoon (2007)
10.1073/PNAS.0601755103
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
O. Farokhzad (2006)
10.1002/MRM.21029
In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain.
C. Heyn (2006)
10.1097/mpa.0b013e318053e7d3
Lifestyle, Occupational, and Reproductive Factors in Relation to Pancreatic Cancer Risk
A. Lo (2007)
10.4161/cbt.11.11.15534
Inactivation of Brca2 cooperates with Trp53R172H to induce invasive pancreatic ductal adenocarcinomas in mice
G. Feldmann (2011)
10.1073/pnas.052029099
Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model
M. Yang (2002)
10.1038/nature06917
Imaging in the era of molecular oncology
R. Weissleder (2008)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar